Boris Rogelj is associate professor at the Jožef Stefan Institute in Ljubljana, Slovenia. He is a molecular biologist/biochemist researching the molecular processes underlying neurodegenerative diseases. His focus is on the pathological RNA-protein interactions and mechanisms underlying ALS and frontotemporal lobar degeneration (FTD).